About
Approach
Pipeline
Publications
- Publications
- Data Presentations
For Patients
Join Us
Investors & Media
Contact Us

test

About▼
- Our Mission▼
- Leadership▼
- Board of Directors▼
Approach▼
Pipeline▼
- Overview▼
- Congenital Hyperinsulinism▼
- Tumor Hyperinsulinism▼
- Diabetic Macular Edema▼
Publications▼
- Publications▼
- Data Presentations▼
For Patients▼
Join Us▼
- Values▼
- Benefits▼
- Open Positions▼
Investors & Media▼
- Overview▼
- Corporate Presentation▼
- News▼
- Events▼
- Stock Quote and Chart▼
  - Historical Data▼
- Analyst Coverage▼
- SEC Filings▼
- Governance▼
- Info▼
Contact Us▼

Stay Connected

Email Alerts Contacts RSS News Feed

©2025 Rezolute, Inc.

Explore

About
Approach
Pipeline
Publications
For Patients
Join Us
Investors & Media
Contact Us

Contact

Corporate Headquarters

275 Shoreline Drive
Suite 500
Redwood City, CA 94065

+1 (650) 206-4507
info@rezolutebio.com

Investor Relations

Oregon Office
2783 NW Lolo Drive
Suite 150
Bend, OR 97703

Legal

Terms of Use
Privacy Notice

MENU

About
Approach
Pipeline
Publications
- Publications
- Data Presentations
For Patients
Join Us
Investors & Media
Contact Us